Vanda Pharmaceuticals Inc. (LON:0LKB)
London flag London · Delayed Price · Currency is GBP · Price in USD
5.05
+0.08 (1.60%)
At close: Dec 3, 2025

Vanda Pharmaceuticals Revenue

Vanda Pharmaceuticals had revenue of $56.26M USD in the quarter ending September 30, 2025, with 18.06% growth. This brings the company's revenue in the last twelve months to $212.07M, up 11.12% year-over-year. In the year 2024, Vanda Pharmaceuticals had annual revenue of $198.77M with 3.18% growth.

Revenue (ttm)
$212.07M
Revenue Growth
+11.12%
P/S Ratio
1.52
Revenue / Employee
$576.29K
Employees
368
Market Cap
239.08M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024198.77M6.13M3.18%
Dec 31, 2023192.64M-61.74M-24.27%
Dec 31, 2022254.38M-14.30M-5.32%
Dec 31, 2021268.68M20.51M8.27%
Dec 31, 2020248.17M20.98M9.23%
Dec 31, 2019227.19M34.07M17.64%
Dec 31, 2018193.12M28.04M16.98%
Dec 31, 2017165.08M19.07M13.06%
Dec 31, 2016146.02M36.09M32.83%
Dec 31, 2015109.93M59.77M119.16%
Dec 31, 201450.16M16.28M48.05%
Dec 31, 201333.88M1.15M3.52%
Dec 31, 201232.73M1.46M4.66%
Dec 31, 201131.27M-4.44M-12.43%
Dec 31, 201035.71M31.16M685.16%
Dec 31, 20094.55M--
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.138.32B
Unilever51.24B
AstraZeneca43.24B
HSBC Holdings43.13B
Rio Tinto Group39.22B
GSK plc32.17B
Barclays26.02B
Revenue Rankings